Barely Significant
← all excerpts

Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study.

Cancers (Basel) · 2020 · PMC7692271 · PMID 33121007

Europe PMCDOI
1
hedged sentence
0.0420
closest p · 0.8× alpha
0.0420
boldest claim

The sentences

approached significancep = 0.042actually significant
This between-treatment difference in OS approached significance in the PAS (median OS 180 vs. 83 days, respectively; HR 0.39; p = 0.042) ( Figure 5 ).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.